Valuation (62%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 77.58 | 25.54 |
| PEG Ratio (TTM) | -2.96 | -26.13 |
| P/S Ratio (TTM) | 0.87 | 2.28 |
| P/B Ratio (TTM) | 2.43 | 45.46 |
| P/FCF Ratio (TTM) | 16.63 | 23.39 |
| Price to 5YR AVG Earnings Ratio | 38.91 | 27.86 |
| Price to 5YR AVG FCF Ratio | 10.97 | 25.72 |
Profitability (20%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 1.20% | 14.76% |
| ROE (TTM) | 3.17% | 307.14% |
| Net Profit Margin (TTM) | 1.10% | 8.96% |
| ROIC 5YR AVG | 4.57% | 45.91% |
Growth (62%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -0.53% | 77.87% | 43.17% |
| Revenue | -1.90% | 1.61% | 1.37% |
| Net Income | -0.44% | 79.12% | 41.56% |
| Cash Flow | 21.47% | 47.62% | 447.10% |
Health (67%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.52 | 1.14 |
| Quick Ratio (TTM) | 0.48 | 0.29 |
| D/E Ratio (TTM) | 0.02 | 6.24 |
| Interest Coverage (TTM) | 13.47 | 10.37 |
| Piotroski F-Score | 7 | 6 |
| Altman Z-Score | 2.22 | 5.48 |
| LTL to 5YR AVG FCF | 4.05 | 21.91 |
| Shares Outstanding Growth 5YR AVG | -3.42% | -3.45% |